Best Life on MSN5d
New Drug Can Reduce COVID Risk By 67%, Research Shows—If You Take It at This Time
Medicines like Paxlovid exist to treat COVID in high-risk people by preventing the virus from multiplying if taken at the ...
AllAfrica on MSN3d
Beyond Dispensing, Drive Research for Better Drug Efficacy - Experts Tell Pharmacists
Scientists have called on pharmacists to prioritise research and ethical practice over immediate financial gain, stressing that the cornerstone of effective pharmacy practice lies in rigorous research ...
Scholar Rock SMA drug shows muscle function benefit
Scholar Rock’s spinal muscular atrophy (SMA) therapy has shown benefit in muscle function in children under 12 in a pivotal ...
Medscape14h
Two-Drug HIV Regimen Matches Standard of Care Therapy in Absence of Drug Resistance Testing
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
Healio59m
Two-drug combination noninferior to current suppressive HIV therapy
Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...
CNET on MSN10d
Natural Medicine vs. FDA Drugs: Which Should You Use for Your Ailment?
FDA-approved drugs are also often patented and subject to various laws regarding exclusivity for a given manufacturer. At the ...
CURE4h
FDA Grants Orphan Drug Designation to PEP-010 in Pancreatic Cancer
The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...
Devdiscourse8d
AI-powered drug repurposing: A game changer for cancer research
The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development.
Pharmabiz13h
Peptris Technologies out-licenses India’s first AI discovered drug candidate to Revio Therapeutics
Peptris Technologies out-licenses India’s first AI discovered drug candidate to Revio Therapeutics: Our Bureau, Bengaluru Monday, March 17, 2025, 12:50 Hrs [IST] Peptris Technol ...
Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
HUMACAO, PUERTO RICO AND NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or ...
Vanguard3d
Beyond dispensing; drive research for better drug efficacy- Experts tell pharmacists
Scientists have called on pharmacists to prioritise research and ethical practice over immediate financial gain, stressing that the cornerstone of effective pharmacy practice lies in rigorous ...